Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session

  1. Home

  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W20--Model Systems to Study Non-pulmonary Manifestations of CF
    Location: 104 C
    Chair: Ben Ross
    Chair: Kyu Shik Mun, PhD – Cedars-Sinai Medical Center
    EPPIMIPTAC/CFTR
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26--I Have a Gut Feeling
    Location: 104 AB
    Chair: Dhiren Patel, MD (he/him/his) – Saint Louis University
    Chair: Jay Freeman, MD, MSc (he/him/his) – Nationwide Children's Hospital
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W20.1- CF mouse model reveals novel roles of CFTR in the kidney and demonstrates features of progressive kidney disease.
    Location: 104 C
    Speaker: Agnieszka Swiatecka-Urban, MD – University of Virginia
    EPPIMIPTAC/CFTR
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W20.2- Recovery of pancreatic functions in CFTR-G551D ferrets after ivacaftor
    Location: 104 C
    Speaker: Yaling Yi, MS – University of Iowa
    EPPIMIPTAC/CFTR
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W20.3- Lactic acid producing bacteria are increased in CFTR-deficient colon crypt microbiota and lactate potentiates clonogenicity and stem cell capacity in colonic organoids and cancer cells.
    Location: 104 C
    Speaker: Patricia Scott, PhD – Univ. of MN Medical School
    EPPIMIPTAC/CFTR
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W20.4- The role of micropeptide BNLN in Cystic Fibrosis Related Diabetes
    Location: 104 C
    Speaker: Tate Neff – University of Iowa
    EPPIMIPTAC/CFTR
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W20.5- Co-culture of mouse enteroids and sensory neurons as a model system to study the gut-brain axis in CF
    Location: 104 C
    Speaker: Oscar O. Morales, MSc (he/him/his) – University of Saskatchewan
    EPPIMIPTAC/CFTR
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.1- Elexacaftor/Tezacaftor/Ivacaftor on Gastrointestinal pH and Motility in CF Adults: Results from PROMISE
    Location: 104 AB
    Speaker: Zachary M. Sellers, MD, PhD – Stanford University
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.2- Improvement in abdominal symptoms (CFAbd-Score) and gut inflammation over 12 months of treatment with Elexacaftor/Tezacaftor/Ivacaftor in children with CF aged 6-11– results from the RECOVER study
    Location: 104 AB
    Speaker: Jane C. Davies, MD MBChB MRCP FMedSci (she/her/hers) – National Heart and Lung Institute, Imperial College London
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.3- The relationship of the CF metabolome to treatment response following CFTR rescue
    Location: 104 AB
    Speaker: Mimi Saavedra, MD – National Jewish Health
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.4- Gastrointestinal pathologies in pediatric cystic fibrosis patients undergoing endoscopy: A single center retrospective review
    Location: 104 AB
    Speaker: Jacob O. Robson, MD, MS (he/him/his) – University of Utah
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.5- A Multi-center Study of Non-invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)
    Location: 104 AB
    Speaker: Christine Hachem, MD (she/her/hers) – Saint Louis University
    EPPCLIN
  • Friday, Sep 27th
    2:30 PM – 4:30 PM ET
    S24--Bridging the Gaps: Extrapulmonary Complications Not Addressed by HEMT
    Location: 104 AB
    Chair: Kim McBennett, MD, PhD – Case Western Reserve University
    Chair: Leah Reznikov, PhD – University of Florida
    EPP